Sobolewski lab: Cancer, Metabolism and RNA
@sobolewskilab.bsky.social
Hi! Our lab is located in the INFINITE unit (U1286-Inserm). Our goal is to characterize the role of RNA-Binding Proteins in the development of Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD) and hepatocellular carcinoma (HCC).
Last article: pubmed.ncbi.nlm.nih.gov/39941720/
Tristetraprolin Family Members and Processing Bodies: A Complex Regulatory Network Involved in Fatty Liver Disease, Viral Hepatitis and Hepatocellular Carcinoma - PubMed
Chronic liver diseases, such as those encountered with obesity, chronic/abusive alcohol consumption or viral infections, represent not only major public health concerns with limited therapeutic option...
pubmed.ncbi.nlm.nih.gov
February 28, 2025 at 10:59 AM
Last article: pubmed.ncbi.nlm.nih.gov/39941720/
Our lab aims at characterizing the role of RNA-Binding Proteins in the development of Fatty Liver Disease and Hepatocellular carcinoma (HCC).
Our goals: better characterization of the diseases and novel therapeutic options! Our team is located in the INFINITE unit (U1286-Inserm)
Our goals: better characterization of the diseases and novel therapeutic options! Our team is located in the INFINITE unit (U1286-Inserm)
February 28, 2025 at 10:55 AM
Our lab aims at characterizing the role of RNA-Binding Proteins in the development of Fatty Liver Disease and Hepatocellular carcinoma (HCC).
Our goals: better characterization of the diseases and novel therapeutic options! Our team is located in the INFINITE unit (U1286-Inserm)
Our goals: better characterization of the diseases and novel therapeutic options! Our team is located in the INFINITE unit (U1286-Inserm)